Saswati Hazra

Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): a multicentre, open-label, randomised, phase 3 trial

Robin Kate Kelley, Lorenza Rimassa, Ann‐Lii Cheng et al. · The Lancet Oncology · 2022 · 494 citations · Full text

mTORC1 Inhibition Is Required for Sensitivity to PI3K p110α Inhibitors in <i>PIK3CA</i> -Mutant Breast Cancer

Moshe Elkabets, Sadhna Vora, Dejan Juric et al. · Science Translational Medicine · 2013 · 344 citations · Full text

Peroxisome Proliferator-activated Receptor γ Induces a Phenotypic Switch from Activated to Quiescent Hepatic Stellate Cells

Saswati Hazra, Shigang Xiong, Jiaohong Wang et al. · Journal of Biological Chemistry · 2004 · 308 citations · Full text

Adipogenic Transcriptional Regulation of Hepatic Stellate Cells

Hongyun She, Shigang Xiong, Saswati Hazra et al. · Journal of Biological Chemistry · 2004 · 293 citations · Full text

Hepatic Stellate Cells, Fatty Liver Disease, Insulin Signaling +16

Antagonism of EGFR and HER3 Enhances the Response to Inhibitors of the PI3K-Akt Pathway in Triple-Negative Breast Cancer

Jessica J. Tao, Pau Castel, Nina Radosevic‐Robin et al. · Science Signaling · 2014 · 164 citations · Full text

Breast Oncology, Oncology, Signaling Pathway +15